FLSM
Frazier Life Sciences Management’s MacroGenics MGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.84M | Hold |
3,175,665
| – | – | 0.15% | 47 |
|
|
2025
Q1 | $4.03M | Hold |
3,175,665
| – | – | 0.18% | 44 |
|
|
2024
Q4 | $10.3M | Buy |
3,175,665
+164,938
| +5% | +$536K | 0.43% | 36 |
|
|
2024
Q3 | $9.91M | Hold |
3,010,727
| – | – | 0.4% | 39 |
|
|
2024
Q2 | $12.8M | Buy |
3,010,727
+539,023
| +22% | +$2.29M | 0.6% | 34 |
|
|
2024
Q1 | $36.4M | Buy |
2,471,704
+70,000
| +3% | +$1.03M | 1.54% | 20 |
|
|
2023
Q4 | $23.1M | Buy |
2,401,704
+598,500
| +33% | +$5.76M | 1.24% | 22 |
|
|
2023
Q3 | $8.4M | Hold |
1,803,204
| – | – | 0.56% | 36 |
|
|
2023
Q2 | $9.65M | Buy |
1,803,204
+100,000
| +6% | +$535K | 0.58% | 32 |
|
|
2023
Q1 | $12.2M | Buy |
+1,703,204
| New | +$12.2M | 0.88% | 27 |
|
|
2022
Q4 | – | Sell |
-701,631
| Closed | -$2.43M | – | 45 |
|
|
2022
Q3 | $2.43M | Buy |
+701,631
| New | +$2.43M | 0.19% | 38 |
|